Are peptides actually 'not that bad for you'? Let's look at the data
Quick answer
The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement. No dosing context, contraindications, or medical supervision is mentioned, and the claim that BPC-157 prevents cancer has no supporting clinical evidence. At least two compounds in the stack (PT-141, testosterone) require a prescription in the United States and are not appropriate for unsupervised self-administration.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @rivi.rl actually say?
The creator rattled off a list of substances they call the "best brain stack" for anyone who "don't give a shit about your health and care about performance." The stack includes semax (called "atomics" in garbled audio), selank, dihexa, testosterone, caffeine, PT-141, Mod GRF or similar peptides, NAD+, L-theanine (likely the "L-wooded Dion" in the transcript), and BPC-157. The most alarming claim came at the end: that BPC-157 is needed "so you don't get cancer." That is a direct disease-prevention claim, and it has no clinical evidence behind it. The video's caption says "this isn't real advice" but still pitches a specific multi-substance protocol to 13,400 viewers, several of whom are presumably taking notes.
Does the science back this up?
Some pieces, partially. Most of it, no. Semax has genuine preclinical data for neuroprotection, primarily in Russian literature. Selank has small human trials suggesting anxiolytic effects without sedation (Uchakina et al., 2014, Eksperimental'naya i Klinicheskaya Farmakologiya). Dihexa is a different story: it's an angiotensin IV analog with rodent cognition data, and essentially zero peer-reviewed human safety data. Testosterone does affect motivation and drive in hypogonadal individuals, that part is not controversial. NAD+ precursors have a legitimate longevity research base (Yoshino et al., 2021, Science). L-theanine paired with caffeine has actual randomized trial support for attention (Haskell et al., 2008, Biological Psychology). BPC-157 has interesting animal healing data but no completed human clinical trials as of 2024. The "don't get cancer" claim for BPC-157 is not supported by any published evidence and directly contradicts responsible communication standards.
What did they get wrong (or right)?
Wrong: The BPC-157 cancer prevention claim is the most serious problem here. There is no peer-reviewed human evidence that BPC-157 prevents cancer. Some animal studies actually raised concerns about its effect on tumor growth in oncological contexts, which makes this claim worse than just unsupported. PT-141 (bremelanotide) is described as "an instant dope means" for motivation, but its approved use is for hypoactive sexual desire disorder in women. Its effect on general motivation or cognitive drive in healthy people is unsubstantiated in controlled research. Dihexa is presented casually despite having no published human pharmacokinetic or safety data. Wrong also: stacking unlicensed peptides with testosterone and stimulants without any mention of medical supervision is genuinely risky. Right, partially: the caffeine plus L-theanine combination is well-supported. Selank's anxiolytic profile is at least grounded in real pharmacology. NAD+ precursors have credible aging research behind them. Credit where it's due, the creator is not entirely making things up, but they're filling large gaps with confidence the evidence doesn't support.
What should you actually know?
Several substances in this stack are not FDA-approved for the uses described and are not legally available as retail supplements in the United States. Dihexa has no human safety profile. PT-141 is a prescription drug approved for a specific indication in women, not a general motivation booster. Stacking peptides with testosterone and stimulants without monitoring creates unpredictable pharmacological interactions that no responsible clinician would recommend without labs, history, and follow-up. The hashtags "highticketsales" and "makemoneyonline" sitting alongside "nootropic" and "peptide" are worth noticing. This video exists in a sales funnel, not a clinical context. Anyone considering any of these substances should consult a licensed provider who can assess individual risk, contraindications, and legality. The disclaimer "this isn't real advice" does not reduce the real-world impact of specific substance recommendations reaching 13,400 viewers.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Are peptides actually 'not that bad for you'? Let's look at the data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
SCENESSE (afamelanotide implant) FDA Prescribing Information
Afamelanotide (an alpha-MSH analog) is the only FDA-approved melanocortin peptide of this class, and only to increase pain-free light exposure in erythropoietic protoporphyria, not for cosmetic tanning.
FDA
Afamelanotide for Erythropoietic Protoporphyria
Randomized placebo-controlled trials (NEJM) behind the afamelanotide approval; this is the legitimate human melanocortin evidence, distinct from unapproved tanning peptides.
PubMed
VYLEESI (bremelanotide injection) FDA Prescribing Information
Bremelanotide (PT-141) is FDA-approved as Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women; approval is limited to that indication.
FDA
Bremelanotide for Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials
Pivotal RECONNECT studies: two double-blind placebo-controlled Phase 3 trials (1,267 women) showing improved sexual desire and reduced distress versus placebo.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Are peptides actually 'not that bad for you'? Let's look at the data is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement.
FormBlends verdict
The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement. No dosing context, contraindications, or medical supervision is mentioned, and the claim that BPC-157 prevents cancer has no supporting clinical evidence. At least two compounds in the stack (PT-141, testosterone) require a prescription in the United States and are not appropriate for unsupervised self-administration.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video recommends an unsupervised multi-compound stack combining experimental peptides (dihexa, BPC-157, semax, selank), a prescription melanocortin agonist (PT-141), testosterone, NAD+ precursors, and stimulants for cognitive and motivational enhancement. No dosing context, contraindications, or medical supervision is mentioned, and the claim that BPC-157 prevents cancer has no supporting clinical evidence. At least two compounds in the stack (PT-141, testosterone) require a prescription in the United States and are not appropriate for unsupervised self-administration.
- BPC-157 has no peer-reviewed human clinical trial data supporting cancer prevention, and some animal research flags concerns about its interaction with tumor angiogenesis.
- PT-141 (bremelanotide) is FDA-approved only for hypoactive sexual desire disorder in women; using it as a motivation enhancer is an off-label application with no controlled evidence in healthy populations.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- BPC-157 has no peer-reviewed human clinical trial data supporting cancer prevention, and some animal research flags concerns about its interaction with tumor angiogenesis.
- PT-141 (bremelanotide) is FDA-approved only for hypoactive sexual desire disorder in women; using it as a motivation enhancer is an off-label application with no controlled evidence in healthy populations.
- Dihexa has zero published human safety data. Its entire evidence base is rodent studies, which makes casual recommendation in a TikTok stack deeply irresponsible.
- Caffeine plus L-theanine is the one combination in this list with solid human RCT support: Haskell et al. (2008) in Biological Psychology showed improved attention and alertness versus either alone.
- NAD+ precursor research is real and growing, including Yoshino et al. (2021) in Science showing metabolic benefits in older adults, but it is a long way from being a validated nootropic stack component.
- Stacking prescription compounds (testosterone, PT-141) with experimental peptides and stimulants without medical supervision creates interaction risks that have not been studied and cannot be predicted from individual compound data alone.
- The hashtags 'highticketsales' and 'makemoneyonline' in a peptide video signal a sales context, not a health education one. Treat the content accordingly.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Rivi · TikTok creator
13.4K views on this video
In all reality none are really that bad for you if you’re smart. This isn’t real advice, do your research. #nootropic #peptide #highticketsales #makemoneyonline
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Rivi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.